FUCHS HENRY J 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 7, 2024
Insider Transaction Report
Form 4
FUCHS HENRY J
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-03-05$85.18/sh−35,341$3,010,396→ 212,117 total
Footnotes (1)
- [F1]The price in column 4 is the weighted average price. The purchase price actually received ranged from $85.01 to $85.31. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.